Clinical Investigations for Prostate Tissue Ablation Devices
US FDA draft guidance. – Clinical Investigations for Prostate Tissue Ablation Devices
Published in Draft Guidance and United States Food and Drug Administration - US FDA
More from Draft GuidanceMore posts in Draft Guidance »
- US draft guidance – Soft (Hydrophilic) Daily Wear Contact Lenses – Performance Criteria for Safety and Performance Based Pathway
- US FDA Update on Laparoscopic Power Morcellators – actions and draft guidance
- US FDA Draft Guidance – FDA Issues Draft Guidance on Arthroscopy Pump Tubing Sets
- US FDA Draft Guidance – Peripheral Percutaneous Transluminal Angioplasty (PTA) and Specialty Catheters – Premarket Notification (510(k)) Submissions
- TGA – IVD companion diagnostics – Guidance on proposed regulatory requirements
More from United States Food and Drug Administration - US FDAMore posts in United States Food and Drug Administration - US FDA »
- EU – Team-NB Position Paper on Documentation Requirements for Drug Device Combination Products Falling in the Scope of Article 117 of MDR 2017/745.
- US – FDA Issues Immediately in Effect Guidance on Ventilators During COVID-19
- US – Ventilator Supply Mitigation Strategies – Letter to Health Care Providers
- US – Update on the Ethylene Oxide Sterilization Master File Pilot Program
- US – FDA Engagement to Mitigate Potential Shortage of Personal Protective Equipment (PPE)
Be First to Comment